In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis
- 1 September 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (9) , 2064-2066
- https://doi.org/10.1128/aac.41.9.2064
Abstract
The antimicrobial activities of amphotericin B, itraconazole, and miconazole against 101 filamentous fungi from patients with cystic fibrosis were tested by a reproducible microdilution method. Itraconazole was very active against Aspergillus species and Scedosporium species (MIC at which 90% of the isolates were inhibited [MIC90], 0.06 to 0.5 mg/liter), whereas amphotericin B was less effective (MIC90, 0.5 to 8 mg/liter).Keywords
This publication has 11 references indexed in Scilit:
- Antifungal Susceptibility Testing: Technical Advances and Potential Clinical ApplicationsClinical Infectious Diseases, 1997
- Invasive aspergillosis after bilateral lung transplantation in cystic fibrosisRespiratory Medicine, 1995
- Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 1995
- Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosisPediatric Pulmonology, 1994
- Allergic Bronchopulmonary Aspergillosis in Patients With Cystic FibrosisChest, 1994
- Allergic Bronchopulmonary Mycosis Caused by:Pseudallescheria boydiiAmerican Review of Respiratory Disease, 1993
- Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosisThe Lancet, 1993
- Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with ItraconazoleChest, 1991
- Microbiology of airway disease in patients with cystic fibrosisClinical Microbiology Reviews, 1991
- Treatment of invasive aspergillosis with itraconazoleThe American Journal of Medicine, 1989